Literature DB >> 8270616

Adenocarcinomas of esophagus and cardia in comparison with gastric carcinoma.

G Heidl1, P Langhans, W Mellin, H Bünte, E Grundmann.   

Abstract

Since the carcinomas of the cardia and the adenocarcinomas of the esophagus show many similarities in their histological and morphological descriptions, a detailed comparative study was attempted on the basis of 66 esophageal carcinomas in adenoid differentiation, 359 carcinomas of the cardia, 1288 gastric carcinomas in infracardial localisation, and 492 squamous carcinomas of the esophagus. The evaluation yielded no significant differences between the adenocarcinomas of the esophagus and the cardia neither in age and sex distribution nor with regard to the classifications of Borrmann, WHO, Ming, and Laurén, but a significant discrimination was possible between esophageal and cardial adenocarcinoma together, on the one hand, and infracardial gastric carcinoma on the other. Furthermore, esophageal adenocarcinomas were localized preferentially in the lower third, unlike squamous carcinomas of the same organ. These results suggest that esophageal adenocarcinoma and carcinoma of the cardia must be considered as one separate entity, probably originating from a common stem cell. They further suggest that the cardia belongs to the esophagus rather than to the stomach.

Entities:  

Mesh:

Year:  1993        PMID: 8270616     DOI: 10.1007/bf01200731

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  27 in total

Review 1.  Barrett's oesophagus.

Authors:  F Potet; V Duchatelle
Journal:  Curr Top Pathol       Date:  1990

2.  Gastric carcinoma. A pathobiological classification.

Authors:  S C Ming
Journal:  Cancer       Date:  1977-06       Impact factor: 6.860

3.  Adenocarcinoma and Barrett's esophagus. An overrated risk?

Authors:  S J Spechler; A H Robbins; H B Rubins; M E Vincent; T Heeren; W G Doos; T Colton; E M Schimmel
Journal:  Gastroenterology       Date:  1984-10       Impact factor: 22.682

4.  Analysis of the records of 1,657 patients with carcinoma of the esophagus and cardia of the stomach.

Authors:  G H Gunnlaugsson; A R Wychulis; C Roland; F H Ellis
Journal:  Surg Gynecol Obstet       Date:  1970-06

5.  Clinical, epidemiologic, and morphologic comparison between adenocarcinomas arising in Barrett's esophageal mucosa and in the gastric cardia.

Authors:  R J Kalish; P E Clancy; M B Orringer; H D Appelman
Journal:  Gastroenterology       Date:  1984-03       Impact factor: 22.682

6.  Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus.

Authors:  R C Haggitt; J Tryzelaar; F H Ellis; H Colcher
Journal:  Am J Clin Pathol       Date:  1978-07       Impact factor: 2.493

7.  Definition of carcinoma of the gastric cardia.

Authors:  A Misumi; A Murakami; K Harada; K Baba; M Akagi
Journal:  Langenbecks Arch Chir       Date:  1989

8.  [Cardia cancer: attempt at a therapeutically relevant classification].

Authors:  J R Siewert; A H Hölscher; K Becker; W Gössner
Journal:  Chirurg       Date:  1987-01       Impact factor: 0.955

9.  Comparative features of esophageal and gastric adenocarcinomas: recent changes in type and frequency.

Authors:  H H Wang; D A Antonioli; H Goldman
Journal:  Hum Pathol       Date:  1986-05       Impact factor: 3.466

10.  Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites.

Authors:  J Powell; C C McConkey
Journal:  Br J Cancer       Date:  1990-09       Impact factor: 7.640

View more
  21 in total

1.  The histological appearance of oesophageal adenocarcinoma--an analysis based on 215 resection specimens.

Authors:  Mario Sarbia
Journal:  Virchows Arch       Date:  2006-02-24       Impact factor: 4.064

2.  Genetic variations associated with telomere length confer risk of gastric cardia adenocarcinoma.

Authors:  Nasha Zhang; Yan Zheng; Jie Liu; Tiansui Lei; Yeyang Xu; Ming Yang
Journal:  Gastric Cancer       Date:  2019-03-21       Impact factor: 7.370

3.  HER-2/neu gene amplification in relation to expression of HER2 and HER3 proteins in patients with esophageal adenocarcinoma.

Authors:  Harry H Yoon; William R Sukov; Qian Shi; Christopher A Sattler; Anne E Wiktor; Robert B Diasio; Tsung-Teh Wu; Robert B Jenkins; Frank A Sinicrope
Journal:  Cancer       Date:  2013-10-21       Impact factor: 6.860

Review 4.  A meta-analysis of interleukin-10-1082 promoter polymorphism associated with gastric cancer risk.

Authors:  Peihua Ni; Hong Xu; Huiping Xue; Bing Lin; Yang Lu
Journal:  DNA Cell Biol       Date:  2012-02-15       Impact factor: 3.311

5.  HER2 positivity in gastric and esophageal adenocarcinoma: clinicopathological analysis and comparison.

Authors:  T Koopman; M M Smits; M Louwen; M Hage; H Boot; A L T Imholz
Journal:  J Cancer Res Clin Oncol       Date:  2014-12-28       Impact factor: 4.553

6.  The columnar-lined mucosa at the gastroesophageal junction in non-human primates.

Authors:  Carlos A Rubio; Edward J Dick; Natalia E Schlabritz-Loutsevitch; Abiel Orrego; Gene B Hubbard
Journal:  Int J Clin Exp Pathol       Date:  2008-01-20

7.  Effect of PSCA gene polymorphisms on gastric cancer risk and survival prediction: A meta-analysis.

Authors:  Tao Zhang; Yuan-Neng Chen; Zhen Wang; Jun-Qiang Chen; Shi Huang
Journal:  Exp Ther Med       Date:  2012-04-30       Impact factor: 2.447

8.  Positive association between Toll-like receptor 4 gene +896A/G polymorphism and susceptibility to gastric carcinogenesis: a meta-analysis.

Authors:  Tian-Hui Zou; Zhen-Hua Wang; Jing-Yuan Fang
Journal:  Tumour Biol       Date:  2013-04-17

9.  Clinicopathologic comparison of Siewert type II and III adenocarcinomas of the gastroesophageal junction.

Authors:  Norihiro Yuasa; Hideo Miyake; Tatsuharu Yamada; Tomoki Ebata; Yuji Nimura; Tatsuo Hattori
Journal:  World J Surg       Date:  2006-03       Impact factor: 3.352

10.  Adverse prognostic impact of intratumor heterogeneous HER2 gene amplification in patients with esophageal adenocarcinoma.

Authors:  Harry H Yoon; Qian Shi; William R Sukov; Mark A Lewis; Christopher A Sattler; Anne E Wiktor; Tsung-Teh Wu; Robert B Diasio; Robert B Jenkins; Frank A Sinicrope
Journal:  J Clin Oncol       Date:  2012-09-17       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.